Showing 12,141 - 12,160 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (largest decrease)) ))', query time: 1.77s Refine Results
  1. 12141

    Group 2 biomechanical testing of fractured limb callus at day 28 after fracture–Mechanical assessment of samples showed a higher twist angle and strain energy in the probiotic treatment post-fracture group with a decrease in torsional stiffness *P<0.05. by Yufa Wang (317537)

    Published 2023
    “…<p>Group 2 biomechanical testing of fractured limb callus at day 28 after fracture–Mechanical assessment of samples showed a higher twist angle and strain energy in the probiotic treatment post-fracture group with a decrease in torsional stiffness *P<0.05.…”
  2. 12142
  3. 12143
  4. 12144

    Intolerance of Uncertainty: A Temporary Experimental Induction Procedure by Oriana Mosca (2814253)

    Published 2016
    “…Participants receiving increasing IU instructions reported greater state-IU, Worry and Negative Affect than those receiving decreasing IU instructions. …”
  5. 12145

    A pooled analysis of the association between sarcopenia and osteoporosis by Zhaowei Teng (10179755)

    Published 2021
    “…Sarcopenia was significantly associated with a greater risk of osteoporosis (OR, 3.10; 95% CI, 2.27–4.23), and each standard deviation increase in relative appendicular skeletal muscle mass was significantly associated with a decreased risk of osteoporosis (OR, 0.64; 95% CI, 0.61–0.67). …”
  6. 12146

    Enrichment of a Myeloid CEBPA Network in HBW Pigs. by Jamie M. Wilkinson (798436)

    Published 2015
    “…The score is calculated by walking down a list of genes ranked by their correlation with the LBW phenotype, increasing a running-sum statistic when a gene in that gene set is encountered (each black vertical line underneath the enrichment plot) and decreasing it when a gene that isn’t in the gene set is encountered. …”
  7. 12147
  8. 12148

    Estimated marginal means for changes in outcome parameters A, B, C, D. by Benjamin Udoka Nwosu (476930)

    Published 2015
    “…<p>A. Hemoglobin A1c: Over the course of our 9 months of observation, the between-treatment differences in HbA1c of 0.4% (9.85% [8.82 to 10.88] for placebo versus 9.46% [8.47 to 10.46] for metformin) was not significant (p = 0.903). …”
  9. 12149
  10. 12150
  11. 12151
  12. 12152

    Costamere gene expression is sensitive to EGR1 levels in NRVMs. by Yi Feng (29944)

    Published 2015
    “…Cell titer blue assay shows a significant decrease in viability in AdEGR1 transduced NRVMs but not the control. …”
  13. 12153

    SETD2 mediates the binding of MALAT1 and pSmads. by Jinqiang Zhang (709289)

    Published 2020
    “…<b>D,</b> Smad2 linker region mutations decrease its capability to form protein complex with PPM1A and SETD2 proteins. …”
  14. 12154

    Expression of pro-fibrotic genes: TGFβ1, COL1A1, DNMT1 and RASAL1 in GTM cells in response to the methylation inhibitor 5-azacytidine. by Fiona McDonnell (2636635)

    Published 2016
    “…We found that DNMT1 was significantly (P<0.05) decreased by 5-azacytidine. Further, the pro-fibrotic genes COL1A1 and TGFβ1 were also significantly (P<0.01) decreased by 5-azacytidine. …”
  15. 12155

    A story about oxygen nanobubbles (RNS60) by Jorge H Ramirez (587826)

    Published 2014
    “…In addition, Revalesio states that RNS60 decrease muscle fatigue and improve exercise performance.[6]</p> <p>Reliant Water is a sport beverage produced by Revalesio and available to the public at the price of $100 USD per 32 bottles. …”
  16. 12156

    Peridomestic Infection as a Determining Factor of Dengue Transmission by Ruth Aralí Martínez-Vega (837538)

    Published 2015
    “…Additionally, we found asymptomatic infections accounted for 60% and a greater age was a protective factor for the presence of symptoms (RR 0.98; 95%CI 0.97–0.99).…”
  17. 12157
  18. 12158
  19. 12159
  20. 12160